Dr. Kevin Sheth graduated from Johns Hopkins University and the University of Pennsylvania School of Medicine. He was a neurology chief resident at Massachusetts General and Brigham & Women's Hospitals. After a fellowship in critical care and vascular neurology at Harvard, he was appointed the first neurology trained intensivist at the R Adams Cowley Shock Trauma Center. Subsequently, he was recruited to Yale as the founding Chief of the Division of Neurocritical Care & Emergency Neurology.
His interests are in the advancement of therapies for devastating acute neurological syndromes, especially those complicated by brain ischemia, swelling and hemorrhage. He is a nationally recognized clinical and translational scientist and has directed several multicenter studies. In pioneering the development of new strategies to treat brain swelling, his work has changed the fundamental approach to brain injury in the ICU and spurned the creation of new technologies in drug delivery and neuroimaging.
At Yale, he serves as the principal investigator for two NIH neuroscience networks, NeuroNEXT and StrokeNet. He is the winner of the prestigious Robert Siekert Award from the American Heart Association (AHA) and the Derek Denny Brown Award from the American Neurological Association. His research has been funded by the NIH, American Academy of Neurology, AHA, and the US Army. Dr. Sheth is the author of over 150 publications and has served on study sections for the NIH, AHA, FDA and NASA.
Dr. Sheth has formed exciting partnerships with entrepreneurs, pharmaceutical companies, and medical device start-ups to bring forward highly innovative solutions. These efforts have resulted in extensive knowledge of FDA pathways, development of phase I-III drug programs, and implementation of new technology into the clinical workspace. His highly collaborative work is dedicated to the improved understanding of neurological disease.